Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$952K Sell
8,932
-222
-2% -$26.9K ﹤0.01% 913
2026
Q1
$1.5M Buy
9,154
+4
+0% +$615 0.01% 695
2025
Q4
$1.59M Buy
9,150
+5,056
+123% +$923K 0.01% 709
2025
Q3
$590K Buy
4,094
+1,710
+72% +$209K ﹤0.01% 934
2025
Q2
$240K Sell
2,384
-909
-28% -$69.5K ﹤0.01% 1367
2025
Q1
$252K Buy
3,293
+147
+5% +$11.2K ﹤0.01% 1324
2024
Q4
$217K Buy
3,146
+166
+6% +$12K ﹤0.01% 1503
2024
Q3
$218K Buy
+2,980
New +$220K ﹤0.01% 1497

Other funds holding INSM

M&T Bank's INSM Position: Q2 2026 in Review

M&T Bank reduced its Insmed (INSM) stake by 2.4% in Q2 2026, selling an estimated $26.9K and leaving 8,932 shares worth $952K. The position accounts for ﹤0.01% of the portfolio, ranked #913.

M&T Bank first reported a position in INSM in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.59M in Q4 2025. 664 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • M&T Bank held 8,932 shares of Insmed worth $952K as of Q2 2026.
  • M&T Bank sold 222 Insmed shares in Q2 2026, an estimated $26.9K.
  • Insmed made up ﹤0.01% of M&T Bank's portfolio in Q2 2026, its #913 holding.
  • M&T Bank first reported a position in Insmed in Q3 2024 and has held it in 8 quarters since.
  • M&T Bank's Insmed position peaked at $1.59M in Q4 2025.
  • 664 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.